Pregnancy diagnostic apparatus
Latest Warner-Lambert Company Patents:
- COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF
- Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- METHODS OF TREATING NEUROFIBROMATOSIS WITH N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE
- Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
- Antibodies to M-CSF
Description
FIG. 1 is a front perspective view of a pregnancy diagnostic apparatus showing my new design;
FIG. 2 is a front view;
FIG. 3 is a right side view;
FIG. 4 is a top view;
FIG. 5 is a bottom plan view with enclosure; and
FIG. 6 is a bottom plan view without the enclosure.
Referenced Cited
Patent History
Patent number: D274752
Type: Grant
Filed: Aug 18, 1983
Date of Patent: Jul 17, 1984
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventor: David S. Byrne (Atlantic Highlands, NJ)
Primary Examiner: Bernard Ansher
Attorneys: Gary M. Nath, Daniel A. Scola, Jr.
Application Number: 6/524,257
Type: Grant
Filed: Aug 18, 1983
Date of Patent: Jul 17, 1984
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventor: David S. Byrne (Atlantic Highlands, NJ)
Primary Examiner: Bernard Ansher
Attorneys: Gary M. Nath, Daniel A. Scola, Jr.
Application Number: 6/524,257
Classifications
Current U.S. Class:
D24/8;
D/9341
